ID

31757

Description

Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01245959

Link

https://clinicaltrials.gov/show/NCT01245959

Keywords

  1. 9/26/18 9/26/18 -
Copyright Holder

Jun Ma, Sun Yat-sen University

Uploaded on

September 26, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Nasopharyngeal Carcinoma NCT01245959

Eligibility Nasopharyngeal Carcinoma NCT01245959

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with newly histologically confirmed non-keratinizing (according to world health organization (who) histologically type).
Description

Histologically confirmed (nasopharyngeal) non-keratinizing (WHO criteria)

Data type

boolean

Alias
UMLS CUI [1,1]
C1334926
UMLS CUI [1,2]
C1518321
UMLS CUI [2]
C1301142
tumor staged as t3-4n1/n2-3 (according to the 7th american joint commission on cancer edition).
Description

Tumor stage (american joint commission on cancer)

Data type

boolean

Alias
UMLS CUI [1]
C0441915
no evidence of distant metastasis (m0).
Description

No distant metastasis

Data type

boolean

Alias
UMLS CUI [1,1]
C1298908
UMLS CUI [1,2]
C1302548
satisfactory performance status: karnofsky scale (kps) > 70.
Description

KPS

Data type

boolean

Alias
UMLS CUI [1]
C0206065
adequate marrow: leucocyte count ≥4000/μl, hemoglobin ≥90g/l and platelet count ≥100000/μl.
Description

Leukocyte, Hemoglobin, Platelet count

Data type

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0019046
UMLS CUI [3]
C0005821
normal liver function test: alanine aminotransferase (alt)、aspartate aminotransferase (ast) <1.5×upper limit of normal (uln) concomitant with alkaline phosphatase (alp) ≤2.5×uln, and bilirubin ≤uln.
Description

ALT, AST, alkaline phosphatase, bilirubin

Data type

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0201836
UMLS CUI [3]
C0201899
UMLS CUI [4]
C0201850
UMLS CUI [5]
C1278039
adequate renal function: creatinine clearance ≥60 ml/min.
Description

Creatinin clearance

Data type

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0373595
patients must be informed of the investigational nature of this study and give written informed consent.
Description

Information about investigation of study, written informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
who type keratinizing squamous cell carcinoma or basaloid squamous cell carcinoma.
Description

WHO type keratinizing/basaloid squamous cell carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0334247
UMLS CUI [1,2]
C1301142
UMLS CUI [2,1]
C1266005
UMLS CUI [2,2]
C1301142
age ≥60 years or <18 years.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
treatment with palliative intent.
Description

Palliative treatment

Data type

boolean

Alias
UMLS CUI [1]
C1285530
prior malignancy except adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer.
Description

Prior malignancy except treated basal/squamous cell cancer, cervical cancer

Data type

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0332300
UMLS CUI [2,2]
C0007117
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C0332300
UMLS CUI [3,2]
C0007137
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C0332300
UMLS CUI [4,2]
C0851140
pregnancy or lactation.
Description

Pregnancy or lactation

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of previous radiotherapy (except for non-melanomatous skin cancers outside intended rt treatment volume).
Description

Prior radiotherapy except for non-melanomatous skin cancers

Data type

boolean

Alias
UMLS CUI [1,1]
C0332152
UMLS CUI [1,2]
C1522449
UMLS CUI [2,1]
C0332300
UMLS CUI [2,2]
C1522449
UMLS CUI [2,3]
C1518408
UMLS CUI [2,4]
C0007114
prior chemotherapy or surgery (except diagnostic) to primary tumor or nodes.
Description

Prior chemotherapy/surgery to primary tumor/nodes (except diagnostic)

Data type

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2,1]
C0744961
UMLS CUI [2,2]
C0677930
UMLS CUI [3,1]
C0744961
UMLS CUI [3,2]
C0024204
UMLS CUI [4,1]
C0332300
UMLS CUI [4,2]
C0430022
any severe intercurrent disease, which may bring unacceptable risk or affect the compliance of the trial, for example, unstable cardiac disease requiring treatment, renal disease, chronic hepatitis, diabetes with poor control (fasting plasma glucose >1.5×uln), and emotional disturbance.
Description

Severe intercurrent disease bringing risk/affectin compliance (unstable cardiac disease, renal disease, chronic hepatitis, diabetes, emotional disturbance)

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0392760
UMLS CUI [1,4]
C0525058
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C1883420
UMLS CUI [2,4]
C0035647
UMLS CUI [3,1]
C0443343
UMLS CUI [3,2]
C0018799
UMLS CUI [3,3]
C0815189
UMLS CUI [4]
C0022658
UMLS CUI [5]
C0019189
UMLS CUI [6,1]
C0011847
UMLS CUI [6,2]
C0583513
UMLS CUI [7]
C0004936

Similar models

Eligibility Nasopharyngeal Carcinoma NCT01245959

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Histologically confirmed (nasopharyngeal) non-keratinizing (WHO criteria)
Item
patients with newly histologically confirmed non-keratinizing (according to world health organization (who) histologically type).
boolean
C1334926 (UMLS CUI [1,1])
C1518321 (UMLS CUI [1,2])
C1301142 (UMLS CUI [2])
Tumor stage (american joint commission on cancer)
Item
tumor staged as t3-4n1/n2-3 (according to the 7th american joint commission on cancer edition).
boolean
C0441915 (UMLS CUI [1])
No distant metastasis
Item
no evidence of distant metastasis (m0).
boolean
C1298908 (UMLS CUI [1,1])
C1302548 (UMLS CUI [1,2])
KPS
Item
satisfactory performance status: karnofsky scale (kps) > 70.
boolean
C0206065 (UMLS CUI [1])
Leukocyte, Hemoglobin, Platelet count
Item
adequate marrow: leucocyte count ≥4000/μl, hemoglobin ≥90g/l and platelet count ≥100000/μl.
boolean
C0023508 (UMLS CUI [1])
C0019046 (UMLS CUI [2])
C0005821 (UMLS CUI [3])
ALT, AST, alkaline phosphatase, bilirubin
Item
normal liver function test: alanine aminotransferase (alt)、aspartate aminotransferase (ast) <1.5×upper limit of normal (uln) concomitant with alkaline phosphatase (alp) ≤2.5×uln, and bilirubin ≤uln.
boolean
C0232741 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201850 (UMLS CUI [4])
C1278039 (UMLS CUI [5])
Creatinin clearance
Item
adequate renal function: creatinine clearance ≥60 ml/min.
boolean
C0232804 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
Information about investigation of study, written informed consent
Item
patients must be informed of the investigational nature of this study and give written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
WHO type keratinizing/basaloid squamous cell carcinoma
Item
who type keratinizing squamous cell carcinoma or basaloid squamous cell carcinoma.
boolean
C0334247 (UMLS CUI [1,1])
C1301142 (UMLS CUI [1,2])
C1266005 (UMLS CUI [2,1])
C1301142 (UMLS CUI [2,2])
Age
Item
age ≥60 years or <18 years.
boolean
C0001779 (UMLS CUI [1])
Palliative treatment
Item
treatment with palliative intent.
boolean
C1285530 (UMLS CUI [1])
Prior malignancy except treated basal/squamous cell cancer, cervical cancer
Item
prior malignancy except adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer.
boolean
C0006826 (UMLS CUI [1])
C0332300 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C0332300 (UMLS CUI [3,1])
C0007137 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C0332300 (UMLS CUI [4,1])
C0851140 (UMLS CUI [4,2])
Pregnancy or lactation
Item
pregnancy or lactation.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Prior radiotherapy except for non-melanomatous skin cancers
Item
history of previous radiotherapy (except for non-melanomatous skin cancers outside intended rt treatment volume).
boolean
C0332152 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0332300 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C1518408 (UMLS CUI [2,3])
C0007114 (UMLS CUI [2,4])
Prior chemotherapy/surgery to primary tumor/nodes (except diagnostic)
Item
prior chemotherapy or surgery (except diagnostic) to primary tumor or nodes.
boolean
C1514457 (UMLS CUI [1])
C0744961 (UMLS CUI [2,1])
C0677930 (UMLS CUI [2,2])
C0744961 (UMLS CUI [3,1])
C0024204 (UMLS CUI [3,2])
C0332300 (UMLS CUI [4,1])
C0430022 (UMLS CUI [4,2])
Severe intercurrent disease bringing risk/affectin compliance (unstable cardiac disease, renal disease, chronic hepatitis, diabetes, emotional disturbance)
Item
any severe intercurrent disease, which may bring unacceptable risk or affect the compliance of the trial, for example, unstable cardiac disease requiring treatment, renal disease, chronic hepatitis, diabetes with poor control (fasting plasma glucose >1.5×uln), and emotional disturbance.
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0392760 (UMLS CUI [1,3])
C0525058 (UMLS CUI [1,4])
C0009488 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C1883420 (UMLS CUI [2,3])
C0035647 (UMLS CUI [2,4])
C0443343 (UMLS CUI [3,1])
C0018799 (UMLS CUI [3,2])
C0815189 (UMLS CUI [3,3])
C0022658 (UMLS CUI [4])
C0019189 (UMLS CUI [5])
C0011847 (UMLS CUI [6,1])
C0583513 (UMLS CUI [6,2])
C0004936 (UMLS CUI [7])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial